Personal reflections on fibrinolytic therapy of acute myocardial infarction [1]

Journal of Thrombosis and Haemostasis

Volumn 4, Issue 3, 2006, Pages 684-685

  Braunwald, E ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; CLOPIDOGREL; ENOXAPARIN; FIBRINOLYTIC AGENT; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; PLASMINOGEN ACTIVATOR; RETEPLASE; STREPTOKINASE; TENECTEPLASE;

ACUTE HEART INFARCTION; ANTICOAGULATION; BETA ADRENERGIC RECEPTOR BLOCKING; BETA ADRENERGIC STIMULATION; BETA HEMOLYTIC STREPTOCOCCUS; BLOOD CLOT LYSIS; BOLUS INJECTION; CLINICAL TRIAL; CORONARY ARTERY BLOOD FLOW; CORONARY ARTERY COLLATERAL CIRCULATION; DRUG INFUSION; DRUG POTENTIATION; FIBRINOLYTIC THERAPY; HEART AFTERLOAD; HEART INFARCTION SIZE; HEART MUSCLE ISCHEMIA; HEART MUSCLE OXYGEN CONSUMPTION; HEART MUSCLE REPERFUSION; HUMAN; LETTER; LUNG EMPHYSEMA; MEDICAL RESEARCH; NONHUMAN; PRIORITY JOURNAL; TACHYCARDIA; VASCULAR PATENCY;

ANIMALS; CLINICAL TRIALS; DOGS; FIBRINOLYTIC AGENTS; HUMANS; MYOCARDIAL INFARCTION; PLATELET AGGREGATION INHIBITORS; THROMBOLYTIC THERAPY;

EID: 33645959826     PISSN: 15387933     EISSN: 15387836     Source Type: Journal    
DOI: 10.1111/j.1538-7836.2006.01801.x     Document Type: Letter

References (24)

1. Braunwald E. 13th Bowditch Lecture. The determinants of myocardial oxygen consumption. Physiologist 1969; 12: 65-93.
2. Braunwald E, Covell JW, Maroko PR, Ross Jr J. Effect of drugs and of counterpulsation on myocardial oxygen consumption. Circulation 1969; 40: 220-8.
3. Maroko PR, Kjekshus JK, Sobel BE, Watanabe T, Covell JW, Ross Jr J, Braunwald E. Factors influencing infarct size following coronary artery occlusion. Circulation 1971; 43: 67-82.
4. Ginks WR, Sybers PR, Maroko PR, Covell JW, Sobel BE, Ross J Jr. Coronary artery reperfusion. II. Reduction of myocardial infarct size at one week after the coronary occlusion. J Clin Invest 1972; 51: 2717-23.
5. Maroko PR, Braunwald E. Modification of myocardial infarct size after coronary occlusion. Ann Intern Med 1973; 79: 720-33.
6. Blumgart HL, Gilligan DR, Schlesinger MJ. Experimental studies on the effect of temporary occlusion of coronary arteries. Am Heart J 1941; 22: 374-89.
7. Tillet W, Garner R. The fibrinolytic activity of hemolytic streptococci. J Exp Med 1933; 58: 485-502.
8. Maroo A, Topol EJ. The early history and development of thrombolysis in acute myocardial infarction. J Thromb Haemost 2004; 2: 1867-70.
9. Tillet W, Sherry S, Read C. The use of streptokinase-streptodornase in the treatment of chronic empyema. J Thorac Surg 1951; 21: 325-41.
10. Sherry S, Fletcher A, Alkjaersigm N, Smyrniotis F. An approach to intravascular fibrinolysis in man. Trans Assoc Am Physicians 1957; 70: 288-96.
11. Chazov EI, Matveeva LS, Mazaev AV, Sargin KE, Sadovskaia GV, Ruda MI. Intracoronary administration of fibrinolysin in acute infarction [in Russian]. Terapeuticheskii Arkhiv 1976; 8: 48.
12. Rentrop P, Blanke H, Karsch KR, Kaiser H, Kostering H, Leitz K. Selective intracoronary thrombolysis in acute myocardial infarction and unstable angina pectoris. Circulation 1981; 63: 307-17.
13. Markis JE, Malagold M, Parker JA, Silverman KJ, Barry WH, Als AV, Paulin S, Grossman W, Braunwald E. Myocardial salvage after intracoronary thrombolysis with streptokinase in acute myocardial infarction: assessment of intracoronary thallium-201. N Engl J Med 1981; 305: 777-82.
14. Gruppo Italiano per lo Studio della Steptochinasi nell'Infarto Miocardico (GISSI). Effectiveness of intravenous thrombolytic treatment in acute myocardial infarction. Lancet 1986; 1: 397-402.
15. The TIMI Study Group. The thrombolysis in myocardial infarction (TIMI) trial. Phase I findings. N Engl J Med 1985; 312: 932-6.
16. Braunwald E. Myocardial reperfusion, limitation of infarct size, reduction of left ventricular dysfunction, and improved survival. Should the paradigm be expanded? Circulation 1989; 79: 441-4.
17. Kim CB, Braunwald E. Potential benefits of late reperfusion of infarcted myocardium: The open artery hypothesis. Circulation 1993; 88: 2426-36.
18. Lamas GA, Flaker GC, Mitchell G, Smith SC, Gersh BJ, Wun C-C, Moye Rouleau JL, Rutherford JD, Pfeffer MA, Braunwald E; for the Survival and Ventricular Enlargement Investigators. Effect of infarct artery patency on prognosis after acute myocardial infarction. Circulation 1995; 92: 1101-9.
19. The GUSTO investigators. An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction. N Engl J Med 1993; 329: 673-82.
20. Cannon CP, Gibson CM, McCabe CH, Adgey J, Schweiger MJ, Sequeira RF, Grollier G, Giugliano RP, Frey M, Mueller HS, Stengart RM, Weaver WD, Van de Werf F, Braunwald E, for the TIMI 10B investigators. TNK-tissue plasminogen activator compared with front-loaded alteplase in acute myocardial infarction: Results of the TIMI 10B trial. Circulation 1998; 98: 205-14.
21. Morrow DA, Antman EM, Sayah A, Schuhwerk KC, Giugliano RP, de Lemos JA, Waller M, Cohen SA, Rosenberg DG, Cutler SS, McCabe CH, Walls RM, Braunwald E on behalf of the Early Retavase-Thrombolysis in Myocardial Infarction (ER-TIMI) 19 Investigators. Evaluation of the time saved by prehospital initiation of reteplase for ST-elevation MI: Results of the Early Retevase (ER)-TIMI 19 trial. J Am Coll Cardiol 2002; 40: 71-7.
22. Sabatine MS, Cannon CP, Gibson CM, Lopez-Sendon JL, Montalescot G, Theroux P, Lewis BS, Murphy SA, McCabe CH, Braunwald E. Effect of clopidogrel pretreatment before percutaneous coronary intervention in patients with ST-elevation myocardial infarction treated with fibrinolysis: The PCI-CLARITY study. JAMA 2005; 294: 1224-32.
23. Antman EM, Louwerenburg HW, Baars HF, Wesdorp JCL, Hamer B, Bassand JP, Bigonzi F, Pisapia G, Gibson CM, Heidbuchel H, Braunwald E, Van de Werf F. Enoxaparin as adjunctive antithrombin therapy for ST-elevation myocardial infarction: Results of the ENTIRE-TIMI 23 trial. Circulation 2002; 105: 1642-9.
24. Antman EM, Morrow DA, McCabe CH, Jiang F, White HD, Fox KAA, Sharma D, Chew P, Braunwald E. Enoxaparin versus unfractionated heparin as antithrombin therapy in patients receiving fibrinolysis for ST-elevation myocardial infarction: Design and rationale for the enoxaparin and thrombolysis reperfusion for acute myocardial infarction treatment -thrombolysis in myocardial infarction study 25 (ExTRACT-TIMI 25). Am Heart J 2005; 149: 217-26.